Zobrazeno 1 - 2
of 2
pro vyhledávání: '"FPV, Favipiravir"'
Autor:
Masahiro Ishizuka, Tsuyoshi Shirai, Tsukasa Okamoto, Takahiro Mitsumura, Yasuhiro Otomo, Kunihiko Takahashi, Meiyo Tamaoka, Yasunari Miyazaki, Tatsuhiko Anzai, Junichi Aiboshi, Tomoya Tateishi, Rie Sakakibara, Takayuki Honda, Yuki Iijima
Publikováno v:
Journal of Infection and Chemotherapy
Background The prediction of COVID-19 disease behavior in the early phase of infection is challenging but urgently needed. MuLBSTA score is a scoring system that predicts the mortality of viral pneumonia induced by a variety of viruses, including cor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8583abb1031e520e0e11ec8b5dfcfbe1
https://doi.org/10.1016/j.jiac.2020.10.013
https://doi.org/10.1016/j.jiac.2020.10.013
Autor:
Cristina Cismaru, Alina Daciana Elec, Adriana Muntean, Tudor Moisoiu, Mihaela Lupșe, Oana Antal, Florin Ioan Elec
Publikováno v:
Transplantation Proceedings
Background: Favipiravir (FPV) is an orally administrable antiviral drug which selectively inhibits RNA-dependent RNA polymerase and which has been repurposed for COVID-19 treatment. There is limited information on the use of FPV in kidney transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2597d0013eee7a41119aedec7c6b29ad
https://pubmed.ncbi.nlm.nih.gov/35065831
https://pubmed.ncbi.nlm.nih.gov/35065831